We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
As part of a Senate Finance Committee investigation, Sen. Chuck Grassley (R-Iowa) is requesting information from Eli Lilly regarding the marketing of its antipsychotic drug Zyprexa.
Drug company spending on direct-to-consumer (DTC) advertising will continue to increase, although drugmakers are worried about potential legislation that would restrict the advertisements, research company Guideline said in a new report.
Drug company spending on direct-to-consumer (DTC) advertising will continue to increase, although drugmakers are worried about potential legislation that would restrict the advertisements, research company Guideline said in a new report.
A congressional committee has requested that Amgen and Johnson & Johnson (J&J) stop direct-to-consumer (DTC) advertising for erythropoiesis-stimulating agents (ESAs).
The FDA needs to strengthen its regulation of direct-to-consumer (DTC) advertising after the agency took more than six months to cite a drugmaker for advertisements suggesting a sleep aid was indicated for use in children, Consumers Union said.
Johnson & Johnson (J&J) has disclosed that three of its subsidiaries have received three separate subpoenas from the Boston, San Francisco and Philadelphia U.S. attorneys’ offices relating to marketing practices for Risperdal, Topamax and Natrecor.
The FDA will conduct two studies to investigate how the context and format of risk information in direct-to-consumer (DTC) print advertisements influence consumers’ understanding of drug risks.
The FDA will conduct two studies to investigate how the context and format of risk information in direct-to-consumer (DTC) print advertisements influence consumers’ understanding of drug risks.
Australia’s Therapeutic Goods Administration and New Zealand’s Medicines and Medical Devices Safety Authority have issued a draft rule on advertising of therapeutic products under the proposed trans-Tasman regulatory agency.
Concerned with Pfizer’s marketing of Viagra, the AIDS Healthcare Foundation (AHF), the largest AIDS healthcare provider in the U.S., has banned the company’s sales representatives from its facilities.